What is the Ownership and Shareholding Structure of Kriya Pharmaceuticals?
In 2018, Kriya Pharmaceuticals had a promoter holding of 48.30% and a public holding of 51.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX